Summary The Hospital Anxiety and Depression (HAD) scale, a self-report questionnaire, was tested as a method of identifying mood disorder among patients with operable breast cancer during the year after diagnosis. In a cohort of 91 patients anxiety and depression were assessed preoperatively, and at 3 and 12 months post-operatively, using a standardised psychiatric interview and diagnostic rating criteria. The patients also completed the HAD scale at each assessment. Fifty out of 91 (55%) patients were full or borderline cases of depression and/or anxiety at one or more assessment points. Using a receiver operator characteristic curve analysis, the optimum threshold for the preoperative HAD scale total score to identify psychiatric disorder either preoperatively or at 3 and 12 months post-operatively was 11. With this threshold 70% of both full and borderline cases occurring at any of the assessment points were correctly identified. The false-positive rate was 12%. This approach was particularly sensitive to full cases, correctly identifying 90% of them. The potential for the preoperative HAD scale total score to identify mood disorder in the year after diagnosis was influenced by age. Among women aged less than 50 years, a preoperative HAD scale total score > 11 provided a highly sensitive indicator of mood disorder (full and borderline cases) at any time in the year after diagnosis (sensitivity = 90%). The false-positive rate was 40%. Among women older than 50 who experienced a mood disorder, only 57% were correctly identified by a HAD scale total score of > 11 (sensitivity = 57%). However, the false-positive rate among older women was low (3%). This simple preoperative screening approach can be used to identify patients who have or are at high risk of developing severe mood disorder in the year after diagnosis. The HAD scale is also sensitive to the detection of borderline mood disorder in patients under the age of 50. It is a specific screening tool among patients over 50, but is not sensitive to the detection of borderline mood disorder in this age group.
About 25% of patients with early breast cancer experience anxiety and depression at any one time in the year after diagnosis (Dean, 1987; Fallowfield et al., 1990) . This includes depressive illnesses and anxiety states as well as borderline mood disorders. During routine medical care only 20-50% of these distressed patients are recognised and referred for appropriate help (Maguire, 1984a) . This identification rate might be increased by improving the communication skills and psychiatric interview techniques of cancer professionals (Maguire, 1984b ).
An alternative approach involves screening for mood disorder by asking patients to complete self-report questionnaires at regular intervals. The effectiveness of the Hospital Anxiety and Depression (HAD) scale (Zigmond and Snaith, 1983) in detecting already existing mood disorder has been assessed in a number of different cancer populations (Razavi et al., 1990 (Razavi et al., , 1992 Hopwood et al., 1991; Ibbotson et al., 1994) , but it has not been evaluated specifically in patients with early breast cancer. Furthermore, the value of the HAD scale as a predictive screening tool to identify those patients at risk of developing mood disorder has not been studied.
Preoperative detection of breast cancer patients with depression and/or anxiety and prediction of those likely to develop such disorder post-operatively is important if psychosocial care is to be given appropriately and effectively. We therefore assessed the utility of the HAD scale administered once, preoperatively, in defining patients who either have or are likely to develop mood disorder in the year after diagnosis. The performance of the HAD scale used in this novel way was compared with the effectiveness of serial HAD scale measurements in detecting concurrent disorder at intervals during the post-operative year. Emphasis was placed on identifying patients with mood disorder whether it be anxiety and/or depression, rather than on the particular nature of mood disorder, as this can be assessed subsequently when the patient is seen by a mental health professional.
Patients and methods
A consecutive series of women presenting to the Clinical Oncology Unit, Guy's Hospital, with operable breast cancer (T1,2 N0,1, MO) between April 1989 and June 1990 and who were aged less than 70 were eligible to participate in the study. Patients were treated according to policies in operation at Guy's during the study period. Briefly, patients with unifocal tumours measuring less than 4 cm in diameter were offered breast conservation therapy. Modified radical mastectomy was recommended for those with larger tumours. Postmenopausal patients normally received adjuvant tamoxifen. Premenopausal patients with positive axillary nodes usually received adjuvant chemotherapy.
Each patient was informed about the study and those who agreed to participate underwent psychological assessment on three occasions; immediately before operation and at 3 and 12 months after operation. Psychiatric symptoms experienced over the previous month were elicited at each assessment using a shortened version of the Present State Examination (PSE) (Wing et al., 1974) . This is a standardised semistructured interview, which was conducted by a research psychologist (SRJ) who was trained in the use of the PSE. Ratings of psychiatric symptoms were discussed at consensus meetings held between PSE trained raters at Guy's Hospital. Diagnoses of anxiety and/or depression were derived using the Bedford College Criteria (Finlay-Jones et al., 1980 Whilst the prevalence of mood disorder overall decreased progressively over the study period, the patterns of anxiety and depression differed substantially. Eighteen of the 34 patients (53%) who were anxious preoperatively had significant levels of anxiety either at 3 months or 12 months post-operatively, or both. Onset of anxiety post-operatively was unusual in patients who had not had clinically significant levels of anxiety preoperatively, occurring in only six cases (four of whom were either also depressed post-operatively or had been preoperatively). In contrast, only five of the 20 (25%) patients who were depressed preoperatively continued to be depressed post-operatively, but 15 patients developed a depression for the first time post-operatively (seven of whom had either concomitant or preceding anxiety).
Mood disorder was to an extent associated with age. Twenty out of 30 (67%) of patients aged less than 50 were borderline or full cases at any time point, compared with 30/61 (49%) patients aged > 50 (P = 0.1). Twelve out of 30 (40%) patients aged less than 50 were full cases, while 8/61 (13%) aged > 50 were full cases (P = 0.006).
Performance of HAD scale total score The potential of the preoperative HAD scale total score to identify patients who experienced mood disorder (full and borderline cases) at any time in the year after diagnosis was examined. This involved assessing the ability of the preoperative HAD scale score to detect current mood disorder and to predict disorder at 3 and 12 months postoperatively. Adopting this approach the ROC curve demonstrated that the optimum threshold was 11 for the HAD scale total score. Using this threshold, 31/37 (84%) patients who were borderline or full cases of anxiety or depression preoperatively were correctly identified, with a false-positive rate of 9/54 (17% borderline cases) at some point in the year after diagnosis were correctly identified (sensitivity = 70%). Five out of 41 women who never experienced mood disorder were incorrectly identified (false-positive rate = 12%). Thirty-five out of 40 of those scoring > 11 were true full or borderline cases (positive predictive value = 88%). The preoperative HAD scale total score was particularly sensitive to full cases, identifying 18/20 (90%) of such patients.
We examined whether the use of serial HAD scale measurements (at 0, 3 and 12 months) to detect concurrent mood disorder could improve on the identification rate described above, using a single preoperative assessment (both for detection and prediction). First we applied a uniform cut-off of HAD scale total score > 11 at each of the three time points. Using this method 31 patients were identified correctly preoperatively (see above). In addition one patient with late onset mood disorder was identified at 3 months. Thus, in total, 32 of the 50 patients who had mood disorder at one or more time points were identified using this approach (sensitivity = 64%).
A further analysis of the utility of serial HAD scale measurements for the detection of concurrent mood disorder was undertaken using optimum cut-off levels derived from ROC curve analyses for each time point. At 3 months the optimum total HAD scale score was five (sensitivity = 77%; specificity = 52%; positive predictive value = 38%). The optimum total HAD scale score at 12 months was six (sensitivity = 77%; specificity = 66%; positive predictive value = 40%). These cut-off points are, of course, well below those usually applied using the HAD scale. Applying these optimum cut-offs to detect late-onset mood disorder, seven patients who developed anxiety or depression at 3 months were identified and four patients who developed mood disorder at 12 months were identified. Combining the use of preoperative HAD scale total score > 11 to identify cases at that time point with the use of the HAD scale total scores using optimum cut-offs at 3 and 12 months, 42/50 cases were identified. However, using this approach, 29 out of 41 who never had mood disorder were incorrectly identified (false positive = 71%).
Effect of age on performance ofpreoperative HAD scale total score Preoperative HAD scale total scores and age were highly significantly inter-related. Twenty-two of the 30 (73%) patients aged less than 50 years had preoperative HAD scale total scores > 11, compared with 18 of 61 (30%) of patients above this age (P = 0.0001). The potential of the preoperative HAD scale total score to identify psychiatric disorder in the year after diagnosis was influenced by age.
A HAD scale total score measured preoperatively provided an effective indication of mood disorder occurring at the time or at 3 and 12 months post-operatively in patients aged less than 50 (Figure 1 ). Eighteen of the 22 patients aged less than 50 years who had preoperative total HAD scale score > 11 experienced mood disorder at some point in the year after diagnosis (positive predictive value = 82%). A preoperative HAD scale score >,11 correctly identified 18 of the 20 patients aged less than 50 years who had mood disorder (full or borderline cases) at any time point during the study (sensitivity = 90%). The remaining two patients had borderline depression at one assessment point only. This threshold score correctly identified all 12 patients aged less than 50 years who were full cases of anxiety or depression at any time point (sensitivity = 100%). Four out of ten patients who never experienced mood disorder were incorrectly classified (false-positive rate = 40%).
Amongst older patients a different pattern was observed. Seventeen out of 18 patients older than 50 who had a preoperative total HAD scale score > 11 experienced mood disorder at some point in the year after diagnosis (positive predictive value = 94%). However, only 17/30 patients in this age group who experienced mood disorder were correctly identified by HAD scale total score > 11 (sensitivity = 57%). Thirty of 31 patients who had no mood disorder during the study period had total HAD scale scores of <11 (falsepositive rate = 3%). Lowering the cut-off for the total HAD score improved sensitivity only slightly, but increased the false-positive rate substantially. The low sensitivity of the preoperative total HAD scale score >,11 in the older group was mainly in relation to borderline cases. Six out of eight patients older than 50 who were full cases were correctly identified (sensitivity = 75%).
Discussion
The prevalence of mood disorder experienced at one or more assessment points in the first year after diagnosis of operable breast cancer in this study is high (22% of patients were full cases and 33% were borderline cases at some point). The point prevalence of mood disorder at each of the three assessment points (41% preoperatively, 29% at 3 months and 25% at 12 months post-operatively) is similar to those reported in other studies, despite the use of somewhat different criteria to define psychiatric illness (Dean, 1987; Fallowfield et al., 1990) . Psychiatric interventions provided during the study by either the unit liaison psychiatrist or general practitioner are therefore unlikely to have affected significantly the prevalence of mood disorder reported in this study. In any case, only a very small number of patients received treatment from the unit psychiatrist during the study period. Details of interventions initiated or given by a general practitioner were not sought in this study. The performance of a single HAD scale total score measured preoperatively in identifying mood disorder occurring at any time in the year after diagnosis was judged to be superior to other approaches using the HAD scale to detect concurrent mood disorder at repeated intervals throughout the year. Administering the HAD scale to identify all cases preoperatively in combination with the HAD scale at 3 and 12 months using optimum cut-offs derived for ROC curve analysis to detect late-onset cases correctly identified more of the women who were anxious or depressed. However, the high proportion of well women who were incorrectly identified, together with the need to administer the HAD I scale on repeated occasions limits the practical utility of this approach in a clinical setting. Similarly the conventional method of using the HAD scale only to detect already existing disorder yields a high false-positive rate, involves repeated administration and lacks the advantage of being able to identify those at risk. The effectiveness of single HAD scale total score in identifying mood disorder in the year after diagnosis lies mainly in its ability to detect early transient mood disorder (i.e. those women who were cases at the preoperative assessment only) and in its ability to detect women whose mood disorder developed early and was sustained (i.e. those with mood disorder both preoperatively and post-operatively).
Among patients aged less than 50, a single HAD scale total score measured preoperatively was an effective indicator of both severe and borderline mood disorder occurring at the time it was performed or during the following year. The findings of this study suggest a simple management policy of administering the HAD scale preoperatively and applying a cut-off of 11 to the total score to identify all younger patients who have or are likely to develop severe mood disorder and 90% of those who are at risk of less severe disorder. From our results 73% of women aged less than 50 will be defined as being at risk. These patients should be interviewed by a specialist nurse trained to elicit psychiatric symptoms using a structured interview. In our series 17 of 22 (77%) women so identified had preoperative mood disorder and these women should be offered appropriate psychological care. Among the remaining five women, one subsequently developed psychiatric disorder. We would therefore recommend that women with a preoperative total HAD scale score > 11 but who are not anxious or depressed at interview (the false positives) should be considered at risk. They should be reassessed by the nurse specialist at least once post-operatively (possibly at 3 months).
Among patients over 50 years, a preoperative total HAD scale score was a highly specific screening tool. It was sensitive for the identification of severe mood disorder but not borderline mood disorder. Slightly less than half of older women who experienced mood disorder according to interview assessment were not high scorers on the HAD scale. This suggests that older women tended not to disclose their psychosocial distress on self-report measures. Whatever the reason, all older patients require regular interview assessment throughout the year after diagnosis (for example 3 and 12 months), if borderline and full case mood disorder is to be diagnosed. We now routinely record patients' total HAD scale scores shortly after diagnosis. This can alert clinicians to patients who have or are at high risk of developing mood disorder. However clinicians should not be falsely reassured by low scores in women over 50 years. Patients are also invited to make contact with the specialist nurse should they develop psychological difficulties at any time.
Women who are found to be full cases of anxiety or depression at interview with the specialist nurse are likely to benefit from structured psychological therapy (e.g. Greer et al., 1992) either alone or in conjunction with psychotropic medication (Costa et al., 1985) . Therefore if they are motivated to receive psychological help this could be initiated by an appropriately trained specialist nurse. Alternatively the nurse could refer them to a psychiatrist or clinical psychologist or liaise with the general practitioner. Women with borderline levels of anxiety and depression are likely to have more diverse needs. Some may benefit from a formal psychological therapy, others from the specialist nurse teaching them self-help techniques for managing anxiety (Snaith, 1992) . It is likely that a considerable proportion experiencing borderline mood disorder preoperatively will require little more than honest, but compassionate explanation and reassurance about their disease and its management from the doctors and nurses responsible for their care.
